NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
03.01.04 Compound bronchodilator preparations

Tiotropium 2.5 micrograms / olodaterol 2.5 micrograms (Spiolto Respimat®)

First Choice

LABA/LAMA

Green Low Carbon

 

Entry Reviewed: September 2022

Aclidinium 340 micrograms/ formoterol 12 micrograms (Duaklir Genuair®)
(Dry powder inhaler)

First Choice

LABA/LAMA

 Green Low Carbon

Entry Reviewed: September 2022

Umeclidinium 55 micrograms / vilanterol 22 micrograms (Anoro Ellipta®)

First Choice

LABA/LAMA

 Green Low Carbon

Entry Reviewed: September 2022

Glycopyrronium and Indacaterol inhaler (Ultibro Breezhaler®)

Formulary

LABA/LAMA

Green Low Carbon

 

Entry Reviewed: September 2022

Glycopyrronium 7.2 micrograms/ formoterol 5 micrograms (Bevespi Aerosphere® )

Formulary

LABA/LAMA

Red Footprint

Higher carbon footprint than other LABA/LAMA options

 

Entry Reviewed: September 2022

Non formulary items

Ipratropium bromide with salbutamol (Combivent®)

DNP
Non Formulary


Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.